Applied Pharmaceutical Innovation has reached another milestone toward bringing the Critical Medicines Production Centre online, completing a factory acceptance test for a downflow booth used in pharmaceutical manufacturing. The organization offered a peek at the progress that's been made. Nobel Prize–winning virologist Michael Houghton, API's chief scientific officer, stressed the value of the CMPC when sharing his vision for Canada's life sciences future in a Q&A tied to National Immunization Awareness Month. "When it's up and running, it will have the capability to manufacture essential medicines at scale, helping Canada respond to future public health emergencies, supply chain disruptions, and emerging healthcare needs," he said.
The progress runs in tandem with plans by Vimy Pharma to produce the first made-in-Canada generic version of drugs like Novo Nordisk's Ozempic with API. Vimy, founded by two former Novo Nordisk staff, shared it plans to go public on Aug. 6, proposing a reverse takeover of Harmony Acquisitions Corp. Health Canada is reviewing the company's submission for a generic semaglutide — the active ingredient in Ozempic and Wegovy. When available, it is projected to cost $75.50 per month compared to $228 for the brand-name version.
Thank you to our sponsors for helping to make our work possible:
Headlines
Alberta Innovates has opened the sixth round of its LevMax-Health Program, which provides funding for Alberta post-secondary researchers with competitive but underfunded applications in research commercialization, clinical trials, and health system transformation. Applications from institutions with Tri-Agency decision letters from February through July 2026 are accepted until Aug. 28.
Researchers from the University of Alberta and the University of Calgary received $250,000 in federal funding to study the microbiome of wildfire smoke, including bacteria, viruses, and fungi that may survive combustion. The project, part of the emerging field of pyroaerobiology, aims to develop a fingerprint of wildfire smoke's chemical and microbial composition to support more effective medical treatment.
Aurinia Pharmaceuticals reported second-quarter revenue of $83.2 million, up 19% from the same period in 2025. The biopharmaceutical company also initiated PRESERVE, a Phase 4 study combining its lupus nephritis drug Lupkynis with other biologic agents.
A new program called Alberta Capital Connect is meant to open doors for early-stage companies in addition to celebrating them at this year's ASTech Awards. The program seeks to connect selected founders to focused, useful feedback on their companies. "This gives us an opportunity to go one level deeper," chair Rus Matichuk told Taproot. He said 35 companies will be selected for meetings with investors and mentors in conjunction with the ASTech opening ceremonies on Sept. 18. Then 15 will move on for deeper feedback, and one will be awarded the Breakout Venture of the Year Award at the ASTech gala on Nov. 6 in Edmonton. The deadline for innovators and advisors to apply is Aug. 18; the deadline for investors and mentors to register is Aug. 31.
The Alberta Machine Intelligence Institute wrapped up its inaugural health-tech startup cohort under its Level Up program, which delivered mentorship and AI guidance to 15 Canadian startups over one year. Five cohort members secured new funding, four achieved clinical launches, and eight underwent complete system architecture evolution, Amii reported.
The FACE Coalition recapped the Edmonton edition of Melamoon 2026, where 20 Black founders pitched on July 18. Health and wellness companies that made the top 10 were ReiSpace, founded by Latoya and Alric Reid; Maison Tchoumzi, founded by Aurelie Tzeuton Nya; Surgizm, founded by Chijindu Ukagwu; and Nurse on Wheels Inc., founded by Tiffany Thompson. They will join 40 other finalists from other Canadian cities to pitch for four $200,000 non-dilutive prizes in Toronto on Oct. 17.
Researchers at the University of Alberta have identified a molecule from hibernating snails that allows cells to survive without oxygen, synthesizing it into a drug called SNAP. Study lead Evangelos Michelakis told Postmedia the drug could extend the shelf life of donated transplant organs and may eventually be used to induce human hibernation for long-duration space travel.
A University of Alberta Faculty of Rehabilitation Medicine partnership that began with four Indonesian clinicians studying in Edmonton in 1994 has grown into "a national movement." Professor Shaniff Esmail helped develop Indonesia's first national occupational therapy curriculum during a sabbatical, and three new programs — including the country's first post-professional master's — will welcome students in September 2026.
Andrew Karesa, founder of blueBell Village, delivered a TEDxUAlberta talk on dementia care, arguing that rigid clinical plans often fail to preserve personhood. Karesa drew on his family's experience supporting his grandmother through Alzheimer's disease to advocate for personalized, relationship-centred support. The latest episode of Karesa's podcast, The Dementia Collective, features a discussion on the misconceptions around dignity in care.
NAIT's Advancing Healthcare Through Simulation podcast explored health data interoperability with Tyler Williamson of the University of Calgary's Centre for Health Informatics and Teri Price of a patient advocacy group called Greg's Wings Projects.
The Life Shouldn't Hurt podcast featured Mat Cardinal, lead singer of country band The Prairie States, who shared his journey from a kidney disease diagnosis at age 10 through daily dialysis and a life-saving transplant at 23. The episode also covers post-operative recovery strategies and staying healthy on tour.
AI4Good Lab marked its 10th anniversary with a Demo Day where participants from Edmonton, Montreal, Toronto, and a virtual cohort presented 16 projects. The Edmonton team's winning project, Feeds, is a forecasting tool designed to help food banks anticipate demand surges using historical data and external indicators from Statistics Canada.
BGCBigs co-executive director Kerry Woodland told the Give Amplify Connect podcast about the organization's youth support continuum for ages six to 24. The episode covers mentoring, after-school programming, employment skills, and the DIVERSIONfirst program, which intervenes to lower the risk of re-offending among young people caught committing a minor offence.
Connect, share ideas, and spark new collaborations
From Sept. 21 to 25, Life Sciences Week brings together industry leaders, policymakers, researchers, innovators, and students for free, community-led events across Alberta. Explore cutting-edge breakthroughs, meet the people transforming bold ideas into real-world solutions, and help shape the future of Alberta's life sciences sector.
Edmonton recorded its worst year on record for overdose deaths in 2025, logging 770 fatal overdoses even as rates fell elsewhere. A city memo said that transit peace officers responded to 2,359 overdose-related events last year, using naloxone 522 times — a 41% increase since 2024. A council committee has since approved a pilot project to expand naloxone training to transit inspectors, though they stopped short of letting any city employee who wants it to volunteer for the overdose-reversal training. University of Alberta physician Sumantra Monty Ghosh dismissed safety concerns raised in a report to community and public services committee, while Civic Service Union 52 president Bryce Jowett said any expansion must let employees opt out "free of coercion or consequences." Council will revisit the issue in October.
Two more people have been infected in a tuberculosis outbreak spreading among people experiencing homelessness in Edmonton's inner city, bringing the total to five confirmed cases tied to a strain first identified in October 2025. The province said risk to the general public remains low, but contact tracing is ongoing. The outbreak "is a concerning and disturbing reflection on health conditions in Edmonton," said infectious disease specialist Stan Houston, adding that long-term control requires addressing the lack of adequate housing. "This is fundamentally not a problem that has a technological solution," he told CBC. "It's a problem that has a social solution. And until we address some of those issues better, TB is not likely to go away."
Alberta medical clinics are taking a wait-and-see approach to a new provincial program that lets patients book and pay for diagnostic imaging tests without a doctor's referral. Medical radiation technologists say Alberta already faces a shortage of about 202 full-time equivalent positions, raising questions about whether the program will increase capacity or extend wait times for publicly referred patients. "If somebody comes over here (with a self-referral), I would probably politely decline," Aurora Diagnostic Imaging owner Tony Alcazar told CBC.
Edmonton-Strathcona MP Heather McPherson criticized Alberta's Bill 11 in an interview with Alberta Primetime, calling it "the biggest attack on public health care in Canadian history." McPherson argued the bill — which lets doctors work simultaneously in public and private clinics — creates a two-tier system that violates the Canada Health Act.
This roundup was sponsored by Applied Pharmaceutical Innovation.
API is one of Canada's largest not-for-profit life sciences commercialization organizations. We catalyze growth in the life sciences sector by addressing key challenges that hold companies and innovators back.
